Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13179751
[patent_doc_number] => 10105363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Histone deacetylase inhibitors and compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/411535
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16691
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411535
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411535 | Histone deacetylase inhibitors and compositions and methods of use thereof | Jan 19, 2017 | Issued |
Array
(
[id] => 16665080
[patent_doc_number] => 10934311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Heterocyclic compound used as FGFR inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/068791
[patent_app_country] => US
[patent_app_date] => 2017-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14134
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 549
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068791
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068791 | Heterocyclic compound used as FGFR inhibitor | Jan 8, 2017 | Issued |
Array
(
[id] => 11908169
[patent_doc_number] => 09776974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Inhibitors of lysine specific demethylase-1'
[patent_app_type] => utility
[patent_app_number] => 15/401894
[patent_app_country] => US
[patent_app_date] => 2017-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40537
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15401894
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/401894 | Inhibitors of lysine specific demethylase-1 | Jan 8, 2017 | Issued |
Array
(
[id] => 15070941
[patent_doc_number] => 10464946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Crystalline forms of thienopyrimidine compound
[patent_app_type] => utility
[patent_app_number] => 16/066341
[patent_app_country] => US
[patent_app_date] => 2016-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 5721
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/066341 | Crystalline forms of thienopyrimidine compound | Dec 29, 2016 | Issued |
Array
(
[id] => 15309005
[patent_doc_number] => 10519193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Steroidal compound, composition containing the same and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/074727
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11484
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074727
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074727 | Steroidal compound, composition containing the same and use thereof | Dec 28, 2016 | Issued |
Array
(
[id] => 17392452
[patent_doc_number] => 11241440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Dihydrooxadiazine compounds for treating infections and cancer
[patent_app_type] => utility
[patent_app_number] => 16/304797
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 11227
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304797 | Dihydrooxadiazine compounds for treating infections and cancer | Dec 28, 2016 | Issued |
Array
(
[id] => 11542578
[patent_doc_number] => 20170096404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/383135
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50508
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/383135 | DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS | Dec 18, 2016 | Abandoned |
Array
(
[id] => 11714829
[patent_doc_number] => 20170183328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/381295
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 36822
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15381295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/381295 | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors | Dec 15, 2016 | Issued |
Array
(
[id] => 14116841
[patent_doc_number] => 10245261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-02
[patent_title] => Substituted indol-5-ol derivatives and their therapeutic applications
[patent_app_type] => utility
[patent_app_number] => 15/379696
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 78
[patent_no_of_words] => 25642
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15379696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/379696 | Substituted indol-5-ol derivatives and their therapeutic applications | Dec 14, 2016 | Issued |
Array
(
[id] => 11589634
[patent_doc_number] => 20170114044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'PYRIDAZINONE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS AND METHODS OF TREATING DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/377149
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 126203
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15377149
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/377149 | PYRIDAZINONE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS AND METHODS OF TREATING DISORDERS | Dec 12, 2016 | Abandoned |
Array
(
[id] => 13777845
[patent_doc_number] => 20190002461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => NOVEL POLYMORPH OF RIOCIGUAT AND ITS PROCESS FOR THE PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/063196
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063196 | Polymorph of Riociguat and its process for the preparation | Dec 11, 2016 | Issued |
Array
(
[id] => 11514221
[patent_doc_number] => 20170081290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => '2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 15/366931
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 243624
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366931 | 2,4-pyrimidinediamine compounds and their uses | Nov 30, 2016 | Issued |
Array
(
[id] => 16293803
[patent_doc_number] => 10770661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Thermally activated delayed fluorescence material and application thereof in organic electroluminescence device
[patent_app_type] => utility
[patent_app_number] => 15/770730
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4725
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770730 | Thermally activated delayed fluorescence material and application thereof in organic electroluminescence device | Nov 29, 2016 | Issued |
Array
(
[id] => 17029671
[patent_doc_number] => 11091476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Protein kinase inhibitors, preparation method and medical use thereof
[patent_app_type] => utility
[patent_app_number] => 15/778812
[patent_app_country] => US
[patent_app_date] => 2016-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18218
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778812
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778812 | Protein kinase inhibitors, preparation method and medical use thereof | Nov 27, 2016 | Issued |
Array
(
[id] => 11499129
[patent_doc_number] => 20170073315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'METHODS OF REGIOSELECTIVE SYNTHESIS OF 2,4-DISUBSTITUTED PYRIMIDINES'
[patent_app_type] => utility
[patent_app_number] => 15/358634
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15426
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15358634
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/358634 | Methods of regioselective synthesis of 2,4-disubstituted pyrimidines | Nov 21, 2016 | Issued |
Array
(
[id] => 11714815
[patent_doc_number] => 20170183315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'SELECTIVE INHIBITORS INTERFERING WITH FIBROBLAST GROWTH FACTOR RECEPTOR AND FRS2 INTERACTION FOR THE PREVENTION AND TREATMENT OF CANCER AND OTHER DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/355506
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12276
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15355506
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/355506 | Selective inhibitors interfering with fibroblast growth factor receptor and FRS2 interaction for the prevention and treatment of cancer and other diseases | Nov 17, 2016 | Issued |
Array
(
[id] => 11956016
[patent_doc_number] => 20170260167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE'
[patent_app_type] => utility
[patent_app_number] => 15/354832
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21058
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354832
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/354832 | Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine | Nov 16, 2016 | Issued |
Array
(
[id] => 12927742
[patent_doc_number] => 09828358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Compositions comprising an inhibitor of lysine specific demethylase-1
[patent_app_type] => utility
[patent_app_number] => 15/344426
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10068
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15344426
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/344426 | Compositions comprising an inhibitor of lysine specific demethylase-1 | Nov 3, 2016 | Issued |
Array
(
[id] => 12001744
[patent_doc_number] => 20170305899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'ANTIBIOTIC COMPOUNDS AND COMPOSITIONS, AND METHODS FOR IDENTIFICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/342056
[patent_app_country] => US
[patent_app_date] => 2016-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 21936
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15342056
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/342056 | ANTIBIOTIC COMPOUNDS AND COMPOSITIONS, AND METHODS FOR IDENTIFICATION THEREOF | Nov 1, 2016 | Abandoned |
Array
(
[id] => 13153913
[patent_doc_number] => 10093668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2)
[patent_app_type] => utility
[patent_app_number] => 15/337332
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9213
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337332
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337332 | Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2) | Oct 27, 2016 | Issued |